Showing 1–12 of 40 peptides
Also known as: N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, PNB-0408
A potent orally active peptide-derived compound that enhances synaptic connectivity through HGF/c-Met signaling, reported to be up to 10 million times more potent than BDNF in some assays.
Also known as: Afamelanotide, Scenesse, NDP-alpha-MSH
A 13-amino-acid synthetic analog of alpha-MSH that selectively stimulates melanin production for photoprotection, FDA-approved for erythropoietic protoporphyria.
Also known as: Mitochondrial ORF of the Twelve S rRNA type-c
A 16-amino-acid mitochondrial-derived peptide that activates AMPK, regulates metabolic homeostasis, and enhances insulin sensitivity and exercise capacity.
Also known as: 5-Amino-1-methylquinolinium
A small-molecule NNMT inhibitor that increases intracellular NAD+ levels and suppresses fat cell formation, researched for metabolic regulation and fat loss.
Also known as: Cibinetide, ZEQLERALNSS
A synthetic 11-amino-acid peptide derived from erythropoietin that selectively activates the innate repair receptor for anti-inflammatory and neuroprotective effects without stimulating red blood cell production.
Also known as: Vasoactive Intestinal Peptide, Aviptadil
A 28-amino-acid neuropeptide with broad immune-modulatory, vasodilatory, and neuroprotective properties, found throughout the central and peripheral nervous system and gut.
Also known as: Ozempic, Wegovy, Rybelsus
A long-acting GLP-1 receptor agonist FDA-approved for type 2 diabetes and chronic weight management, achieving ~15-17% body weight reduction in clinical trials.
Also known as: LY3437943, Reta
An investigational triple hormone receptor agonist (GIP/GLP-1/glucagon) that achieved up to 24.2% body weight reduction in Phase 2 trials, representing the next frontier in metabolic peptide therapy.
Also known as: HN, HNG (S14G-Humanin)
A 24-amino-acid mitochondrial-derived peptide with cytoprotective properties, researched for protection against oxidative stress, neurodegeneration, and age-related cellular damage.
Also known as: Elamipretide, MTP-131, Bendavia
A synthetic mitochondria-targeted tetrapeptide that stabilizes cardiolipin in the inner mitochondrial membrane, improving energy production and reducing oxidative stress.
Also known as: Mounjaro, Zepbound, LY3298176
A first-in-class dual GIP/GLP-1 receptor agonist FDA-approved for type 2 diabetes and weight management, achieving up to ~22.5% body weight reduction.
Also known as: Proxofim, FOXO4-D-Retro-Inverso
A 49-amino-acid senolytic peptide that selectively induces apoptosis of senescent cells by disrupting the FOXO4-p53 interaction, restoring tissue function in aged organisms.